Metformin and lactic acidosis in diabetic humans.
Lalau
J D
JD
Service d'Endocrinologie-Nutrition, H pital Sud, Amiens, France. lalau@burotec.fr
Race
J M
JM
D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000401:mortality; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000401:mortality; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008687:Metformin / Q000009:adverse effects* / Q000627:therapeutic use; D010629:Phenformin / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis
D007004:Hypoglycemic Agents; D008687:Metformin; D010629:Phenformin